ReviewERJ open research2018
Noninvasive ventilation in stable hypercapnic COPD: what is the evidence?
Review in ERJ open research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Chronic obstructive pulmonary disease (COPD) and COPD-like phenotypes.Frontiers in medicine · 2024Review
- International Consensus Statement on Obstructive Sleep Apnea.International forum of allergy & rhinology · 2023Review
- Ventilatory neural drive in chronically hypercapnic patients with COPD: effects of sleep and nocturnal noninvasive ventilation.European respiratory review : an official journal of the European Respiratory Society · 2022Review
- Application of Acupoint Catgut Embedding Therapy Combined with Liuzijue Breathing Exercise in the Treatment of Patients with Stable Chronic Obstructive Pulmonary Disease.Evidence-based complementary and alternative medicine : eCAM · 2022Article
- Mortality and Healthcare Use of Patients with Compensated Hypercapnia.Annals of the American Thoracic Society · 2021Article
- Assistive technologies for home NIV in patients with COPD: feasibility and positive experience with remote-monitoring and volume-assured auto-EPAP NIV mode.BMJ open respiratory research · 2021Article
- Living conditions and autonomy levels in COPD patients receiving non-invasive ventilation: impact on health related quality of life.BMC pulmonary medicine · 2021Observational
- Long-Term Domiciliary Noninvasive Ventilation for COPD.Respiratory care · 2021Article
- Contemporary Concise Review 2019: Sleep and ventilation.Respirology (Carlton, Vic.) · 2020Review
- A Low-Cost Breath Analyzer Module in Domiciliary Non-Invasive Mechanical Ventilation for Remote COPD Patient Monitoring.Sensors (Basel, Switzerland) · 2020Article
- Psychosocial Interventions for Patients with Severe COPD-An Up-to-Date Literature Review.Medicina (Kaunas, Lithuania) · 2019Review
- Health-related quality of life as predictor for mortality in patients treated with long-term mechanical ventilation.BMC pulmonary medicine · 2019Article
- Diagnosis and management of chronic obstructive pulmonary disease in Serbia: an expert group position statement.International journal of chronic obstructive pulmonary disease · 2019Review
- Stable Chronic Obstructive Pulmonary Disease (COPD) Management Under a Tiered Medical System in China.International journal of chronic obstructive pulmonary diseaseArticle
- Clinical Evidence of Nasal High-Flow Therapy in Chronic Obstructive Pulmonary Disease Patients.Respiration; international review of thoracic diseasesReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Long-term noninvasive ventilation (NIV) to treat chronic hypercapnic respiratory failure is still controversial in severe chronic obstructive pulmonary disease (COPD) patients. However, with the introduction of high-intensity NIV, important benefits from this therapy have also been shown in COPD. In this review, the focus will be on the arguments for long-term NIV at home in patients with COPD. The rise of (high-intensity) NIV in COPD and the randomised controlled trials showing positive effects with this mode of ventilation will be discussed. Finally, the challenges that might be encountered (both in clinical practice and in research) in further optimising this therapy, monitoring and following patients, and selecting the patients who might benefit most will be reviewed.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.